Remove Competition Remove Marketing Remove Pricing Remove San Diego
article thumbnail

Bio Roundup: Rare Disease Showdowns, Prices on TV, Dealmania & More

Xconomy

The market for drugs for rare or “orphan” diseases continues to grow. The field has gotten so competitive that multiple products are on the market for some diseases. Patients with the rare, debilitating transthyretin amyloidosis had no marketed. Soon there could be three.

Pricing 97
article thumbnail

Sundae snags $36M to build out its distressed property marketplace

TechCrunch LA

He did note that in the four markets where the company has gone live since launching its business in January 2019 — San Diego, Los Angeles, the Inland Empire , and Sacramento — has yielded an annualized revenue run rate of over $400 million in gross merchandise value (the total value of home sales transacted on its platform).

Sales 282
Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

Bio Roundup: Leiden’s Exit, Depression Data, a New Pricing Bill & More

Xconomy

He steered Vertex through a crisis when its hepatitis C business was squashed by competition. Vertex surprised Wall Street this week by announcing Leiden’s seven-year run will end next spring. In some ways, his legacy is already written.

Pricing 77
article thumbnail

Bio Roundup: Agile Approval, Coronavirus Collabs, Spruce’s $88M & More

Xconomy

The price of insulin, a life-saving treatment discovered a century ago, has been a flashpoint amid the broader drug pricing debate. The FDA is trying to tame high insulin prices by encouraging price competition. The FDA has historically regarded insulin as a drug.

Pricing 79
article thumbnail

Pharmaceutical Price Controls Might Be Closer Than You Think

Xconomy

Amid the hue and cry over the Mylan EpiPen pricing debacle , Hillary Clinton unveiled her “ Plan to Respond to Unjustified Price Hikes for Long-Available Drugs. ” Clinton’s plan calls for “dedicated oversight to protect consumers.” That dependence on price increases won’t change any time soon. It has started.”

Pricing 40
article thumbnail

Bio Roundup: Generic Drugs Graft, ASCO Ahead, ElevateBio Rises & More

Xconomy

During his tenure as FDA commissioner, Scott Gottlieb often spoke about generics as a market force that could help tame climbing drug prices. A lawsuit is now claiming that many top generic drug makers routinely conspired to avoid competition. But such tools only work when companies play fair.

Pricing 79
article thumbnail

Interview with Noah Auerhahn, Extrabux

socalTECH

For this morning's interview, we talked with Noah Auerhahn , President of San Diego-based Extrabux (www.extrabux.com), an online site focused on providing consumers with comparison shopping combined with discount offers. That's where the original concept came from--so we wrote up the plan, and it won the competition.

USC 207